Clariant shares are traded at virt-x, the home market for the Swiss Market Index (SMI) stocks.
The stock symbol for Clariant shares is CLN.
Clariant’s Initial Public Offer was in 1995.
Based on the notifications received by Clariant and published by SIX Exchange Regulation, as at 31 December 2016 the following shareholders held more than 3% of voting rights in Clariant:
Shareholders Voting rights Group of former shareholders of Süd-Chemie AG1 13.89 % Thereof (as a separate sub-group): Blue Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) and Maple Beteiligungsgesellschaft mbH, Am Holzmaierfeld, 82064 Grossdingharting (Germany) 2 3.73 % APG Asset Management N.V., Amsterdam, Netherlands 5.01 % BlackRock Inc., New York 3.08 % Cymbria, Canada
EdgePoint Global Portfolio, Canada
EdgePoint Canadian Growth and Income Portfolio, Canada
EdgePoint Canadian Portfolio, Canada
EdgePoint Global Growth and Income Portfolio, Canada
St. James Place Global Equity Unit Trust, UK
3.06 % Citadel Multi-Strategy Equities Sàrl
Citadel Global Equities Fund Sàrl
Citadel Securities (Europe) Limited
3.02 % Norges Bank (the Central Bank of Norway) 3.003 % UBS Funds Management (Switzerland) AG 3.001 % Wilhelm, Dr. Winterstein, Germany
Dolf, Dr. Stockhausen, Switzerland
Axel, Dr. Schweighart, Germany
Rosemarie Schweighart, Germany
Dominique Kraus, Germany
Karl, Dr. Wamsler, Germany
Irene W. Banning, United States
Susanne Wamsler-Singer, Austria
Caroline A., Dr. Wamsler, United States
Amelie Ratjen, Germany
Christof Ratjen, Germany
Christopher Weithauer, Germany
Johanna Bechtle, Germany
Kaspar Bechtle, Germany
Luisa Redetzki, Germany
Karl T. Banning, United States
Schuyler H. Joerger, United States
Konstantin Alfred Winterstein, Germany
Max-Theodor, Dr. Schweighart, Germany
Peter, Dr. Schweighart, Germany
Moritz Ostenrieder, Germany
Christian Ratjen, Germany
Bettina Wamsler, Germany
Pauline Joerger, United States
Marianne Kunisch, Germany
Maximilian Ratjen, Germany
Julius Ratjen, Germany
Elisabeth Prinzessin zu Sayn-Wittgenstein, Germany
Georg A. Weithauer, Germany
Charlotte Bechtle, Germany
Clara Redetzki, Germany
Marie Redetzki, Germany
Sophia P. Joerger, United States
2According to a disclosure notification published on 18 January 2013, a group consisting of Konstantin Winterstein, 80333 München, Germany and Elisabeth Prinzessin zu Sayn-Wittgenstein, 80333 München, Germany holds 3.73% partially through Blue Beteiligungsgesellschaft mbH, Grossdingharting (Germany) and partially through Maple Beteiligungsgesellschaft mbH, Grossdingharting (Germany). The 3.73% held by this group are included in the 13.89% mentioned under footnote 1, but build a separate sub-group.
Disclosure notifications during the financial year 2014 notified to the Stock Exchange Disclosure Office pursuant to Art. 20 of the Stock Exchange Act can be found on the SIX Swiss Exchange reporting platform: http://www.six-exchange-regulation.com/obligations/disclosure/major_shareholders_de.html
As of 31 December 2016, the fully paid nominal share capital of Clariant Ltd totaled CHF 1 288 175 036.30 and was divided into 331 939 199 registered shares, each with a par value of CHF 3.70. Clariant Ltd shares have been listed on the SIX Swiss Exchange since 1995 (symbol: CLN, ISIN CH0012142631). Clariant Ltd does not issue non-voting equity securities (Genussscheine).
Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. Our business units are divided into six market segments: Consumer Care, Industrial Applications, Plastics & Coatings, Energy, Resources, and Bio Tech.
Clariant is divided into seven Business Units. The Business Units have operational autonomy within the overall group strategy, and are entirely responsible for their own business success. Clariant’s business units are divided into four Business Areas: Care Chemicals, Catalysis, Natural Rescources and Plastics & Coatings.
Clariant has a strong heritage going back to the 1850s with roots in both Sandoz and Hoechst Specialty Chemicals. In 1995, Clariant was established by demerger from Sandoz Chemicals Division. In 1997, Clariant bought Hoechst Speciality Chemicals and in 2011, Clariant acquired Süd-Chemie.
Roughly 17 440 employees in more than 100 group companies on five continents generate annual sales of around CHF 5 847 m (full year 2016 reported figures from continuing operations).
You won't find the name of our company on products in a department store. But some of our brands have been well-known for years in the marketplace. Just follow the links in the Key Business Facts section of this website to access the corresponding websites or search by trade names.
Clariant’s main strengths are expertise, applications experience and market knowledge combined continually in creative ways. Clariant is committed to sustainable growth springing from its own innovative strength.
At Clariant, R&D is a key driver to generate profitable growth. Four Technology Platforms are the basis to develop innovative products for today’s and tomorrow’s markets: Chemistry & Materials, Biotechnology, Catalysis and Process Technology. Clariant’s R&D Centers are shaped along these Technology Platforms and are connected with the world-wide network of Technical Centers of our Business Units to combine technology and application know-how to quickly respond to customer needs. About 6 500 patents safeguard our knowledge about products and methods. In 2016, the Group spent CHF 206 million on R&D, or about 3.5% of sales. Clariant employs approximately 1 100 people in R&D, primarily in Germany, North America, China, and India. The new Clariant Innovation Center (CIC) located in Frankfurt is Clariant’s global flagship for R&D centrally steered via Clariant International Ltd. in Switzerland.
Clariant is committed to generating sustainable added value. This is only possible if ecological, social as well as economic objectives are met. Our highest priorities are personal safety and environmentally sound processes and products.
For more information, please visit our Sustainability section.Sustainability
Clariant has implemented modern corporate governance structures to ensure accountability, responsibility and transparency throughout the Group and for its shareholders. Corporate governance reporting is in compliance with the guidelines of SIX Swiss Exchange and the Swiss Code of Best Practices in Corporate Governance.
The way we do business is a key element for our reputation. Clariant wants to be perceived as a world-class performance company and by the same token, as a reliable and integral partner of our stakeholders all over the world. We are convinced that sustainable business success is closely linked to compliance with laws, regulations and ethical standards. Please visit the Clariant's Code of Conduct Webpage for additional information.
2.500 2012-2018 CH0188295239 3.250 2012-2019 CH0181721629 3.500 2012-2022 CH0188295312 2.125 2014-2024 CH0253592759
You can update your address data by contacting the bank maintaining your securities account. Alternatively you may submit your changes directly to the shareholder register - email: firstname.lastname@example.org.